Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 10/10/2019 - 00:03 Home Read more about Statement of changes in beneficial ownership of securities
Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk? Submitted by amarin on Mon, 10/07/2019 - 21:12 Home Read more about Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?
Comparing eicosapentaenoic acid between plasma and serum from a randomized, controlled clinical trial Submitted by amarin on Mon, 10/07/2019 - 21:07 Home Read more about Comparing eicosapentaenoic acid between plasma and serum from a randomized, controlled clinical trial
August 8th Conference Call Submitted by amarin on Fri, 10/04/2019 - 20:17 Home Read more about August 8th Conference Call
Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus Submitted by amarin on Fri, 10/04/2019 - 19:37 Home Read more about Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
The editor’s roundtable: current perspectives on triglycerides and atherosclerosis Submitted by amarin on Fri, 10/04/2019 - 19:35 Home Read more about The editor’s roundtable: current perspectives on triglycerides and atherosclerosis
Omega-3 fatty acid formulations in cardiovascular disease: dietary supplements are not substitutes for prescription products Submitted by amarin on Fri, 10/04/2019 - 19:33 Home Read more about Omega-3 fatty acid formulations in cardiovascular disease: dietary supplements are not substitutes for prescription products
Improving lipids with prescription icosapent ethyl after previous use of fish oil dietary supplements Submitted by amarin on Fri, 10/04/2019 - 19:31 Home Read more about Improving lipids with prescription icosapent ethyl after previous use of fish oil dietary supplements
Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease Submitted by amarin on Fri, 10/04/2019 - 19:30 Home Read more about Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease
A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States. Submitted by amarin on Fri, 10/04/2019 - 19:28 Home Read more about A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States.
